Letter: Vaccination against whooping cough. 1974

J S Dodge

UI MeSH Term Description Entries
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014917 Whooping Cough A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath. Pertussis,Bordetella pertussis Infection, Respiratory,Cough, Whooping,Pertusses

Related Publications

J S Dodge
November 1975, British medical journal,
J S Dodge
December 1975, British medical journal,
J S Dodge
November 1974, Lancet (London, England),
J S Dodge
September 1974, Lancet (London, England),
J S Dodge
October 1974, Lancet (London, England),
J S Dodge
May 1976, Lancet (London, England),
J S Dodge
May 1976, Lancet (London, England),
J S Dodge
April 1976, Lancet (London, England),
J S Dodge
April 1975, Lancet (London, England),
J S Dodge
May 1975, Lancet (London, England),
Copied contents to your clipboard!